These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8261688)

  • 1. Relationship of the antihypertensive effect of vasopressin withdrawal to sodium excretion in the Doca-salt hypertensive rat.
    Wang H; Wilson N; McNeill JR
    Clin Invest Med; 1993 Oct; 16(5):348-57. PubMed ID: 8261688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of sodium and water excretion in the antihypertensive effect of vasopressin in the spontaneously hypertensive rat.
    Chiu EK; Wang H; McNeill JR
    Can J Physiol Pharmacol; 1992 Oct; 70(10):1309-14. PubMed ID: 1490249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
    Chen YF; Jin HK; Paul R; Nagahama S
    J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.
    Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S
    J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats.
    Diaz J; Ni W; Thompson J; King A; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2008 Jun; 325(3):1031-8. PubMed ID: 18305011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
    Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H
    J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular, renal, and endocrine responses to low-dose atrial natriuretic peptide in the fluid-balanced New Zealand genetically hypertensive rats with and without endogenous arginine vasopressin.
    Abu-Amarah I; Balment RJ
    Can J Physiol Pharmacol; 1999 Feb; 77(2):102-10. PubMed ID: 10535700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a chronic infusion of atrial natriuretic peptide on sodium balance in normotensive and two-kidney, one-clip hypertensive rats.
    Fenoy FJ; Salazar FJ; Hernández I; Pinilla JM; Quesada T
    Clin Physiol Biochem; 1990; 8(5):256-60. PubMed ID: 2151754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CNS-induced natriuresis, neurohypophyseal peptides and renal dopamine and noradrenaline excretion in prehypertensive salt-sensitive Dahl rats.
    Sjöquist M; Lee SL; Hansell P
    Exp Physiol; 2005 Nov; 90(6):847-53. PubMed ID: 16091405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex difference in pressor responsiveness to vasopressin and baroreflex function in DOC-salt hypertensive rats.
    Ouchi Y; Share L; Crofton JT; Iitake K; Brooks DP
    J Hypertens; 1988 May; 6(5):381-7. PubMed ID: 3385203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal-induced antihypertensive effect of vasopressin: role of the L-arginine/nitric oxide pathway.
    Talom RT; McNeill JR
    Can J Physiol Pharmacol; 1997 Jul; 75(7):812-7. PubMed ID: 9315348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal-induced antihypertensive effect of vasopressin in Doca-salt hypertension.
    Chiu EK; McNeill JR
    Am J Hypertens; 1989 Jun; 2(6 Pt 1):458-61. PubMed ID: 2757802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal, endocrine and vascular effects of atrial natriuretic peptide in a novel vasopressin-deficient genetically hypertensive strain of rat.
    al-Barazanji KA; Balment RJ
    Exp Physiol; 1995 Mar; 80(2):275-84. PubMed ID: 7786518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acute vasopressin infusion on blood pressure and plasma angiotensin II in normotensive and DOCA-salt hypertensive rats.
    Morton JJ; Garcia del Rio C; Hughes MJ
    Clin Sci (Lond); 1982 Feb; 62(2):143-9. PubMed ID: 7053914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance receptors for atrial natriuretic petide in Milan hypertensive and normotensive rats.
    Aptel HB; Wannop DW; al-Busada K; Henderson IW
    J Hypertens; 1996 Apr; 14(4):461-8. PubMed ID: 8761895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume sensitive hypertension and the digoxin-like factor. Reversal by a Fab directed against digoxin in DOCA-salt hypertensive rats.
    Krep H; Price DA; Soszynski P; Tao QF; Graves SW; Hollenberg NK
    Am J Hypertens; 1995 Sep; 8(9):921-7. PubMed ID: 8541008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.